Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers

•Anti-SP antibody titer compared after second and third doses of the BNT162b2 vaccine.•Study conducted on healthcare workers directly exposed to COVID-19 patients.•Anti-SP IgG titer decreased slowly after second dose of the vaccine.•Peak IgG titer 4.1-fold higher after the third dose than after firs...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2023-01, Vol.41 (2), p.365-371
Hauptverfasser:	Tanaka, Hidenori, Mukai, Junji, Kushibiki, Kenichi, Mizushima, Sayuri, Maeda, Kyoko, Fujimoto, Yuko, Sawada, Ryugo, Oda, Manabu, Okuda, Hiroshi, Yamaki, Mayumi, Hashiguchi, Shin, Kawai, Ichiro, Kawaguchi, Izumi, Masuda, Noriyuki, Matsushita, Haruhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Aged Antibodies Antibodies, Viral Antibody Formation Antibody response BNT162 Vaccine BNT162b2 vaccine Booster vaccination Chemiluminescence Coronaviruses COVID-19 COVID-19 - prevention & control COVID-19 Vaccines Enzyme immunoassay Female Health care Health Personnel Healthcare workers Humans IgG antibody Immunization Immunoassay Immunoglobulin G Longitudinal Studies Male Males Medical personnel mRNA mRNA Vaccines Nucleocapsids Pandemics Proteins Questionnaires SARS-CoV-2 SARS-CoV-2 spike protein Severe acute respiratory syndrome coronavirus 2 Sex differences Spike protein Vaccines Values
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!